Guohua Zeng

Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods

G. Zeng, Xiaolu Duan, Zihao He, 2019, PeerJ.

LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.

Xiaolu Duan, T. Deng, R. Yang, 2023, Cellular signalling.

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma

G. Zeng, W. Zhong, Yuanfa Feng, 2022, Frontiers in Immunology.

A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy

T. Deng, Yulong Xu, R. Yang, 2023, BMC Medicine.